Expert Perspectives on Advances in the Management of C. difficile : Episode 12

Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections

January 8, 2021

Video

Implications for prescribing vancomycin or fidaxomicin to treat C. difficile infections.

EP: 1.C. Difficile Risk Factors and Manifestation

EP: 2.Strains of C. Difficile

EP: 3.Managing Community-Onset C. Difficile

EP: 4.Recurrent C. Difficile

EP: 5.C. Difficile: A Differential Diagnosis

EP: 6.Testing for C. Difficile Infections

EP: 7.Screening for C. Difficile

EP: 8.C. Difficile: Clinical Practice Guidelines and Treatment Options

EP: 9.C. Difficile: Updates to Clinical Practice Guidelines

EP: 10.Selecting Therapy to Treat C. Difficile

EP: 11.C. Difficile Treatment: Fidaxomicin

EP: 12.Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections

EP: 13.C. Difficile Treatment: Bezlotoxumab

EP: 14.Preventing/Treating C. Difficile: Unmet Needs

EP: 15.Fecal Microbiota Transplantation for C. Difficile Infections

EP: 16.Emerging Treatment Options for C. Difficile Infections

EP: 17.C. Difficile: Barriers Treating With FMT

EP: 18.Making Strides in the Management of C. Difficile

Recent Videos

Contagion, Spring 2025 Digital Edition

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.